{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:23:54Z","timestamp":1792423434819,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,4]],"date-time":"2018-06-04T00:00:00Z","timestamp":1528070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,6,4]],"date-time":"2018-06-04T00:00:00Z","timestamp":1528070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Protein tyrosine kinase 7 (PTK7), also known as colon carcinoma kinase 4 (CCK-4), is a member of the catalytically defective receptor protein tyrosine kinase family and is upregulated in various cancers, where it is known to act as either an oncoprotein or a tumor suppressor. To understand the contrasting roles of PTK7 in tumorigenesis, we analyzed the tumorigenic characteristics of esophageal squamous cell carcinoma (ESCC) cells with low levels of endogenous PTK7 expression (TE-5 and TE-14 cells) and high levels of expression (TE-6 and TE-10 cells) after transfections with a PTK7 expression vector. PTK7 overexpression increased the proliferation of TE-5 and TE-14 cells but decreased the proliferation of TE-6 and TE-10 cells. In the ESCC cells, proliferation, migration, and invasion were initially increased and then decreased according to PTK7 expression levels, which were mirrored by initial increases and then decreases in the tyrosine phosphorylation of cellular proteins and phosphorylation of Src, Akt, and ERK. In ESCC patients included in The Cancer Genome Atlas database, those with higher PTK7 mRNA levels had a longer overall survival and lower relative risk than those with lower PTK7 mRNA levels. These results demonstrate that PTK7 biphasically regulates tumorigenesis in ESCC.<\/jats:p>","DOI":"10.1038\/s41598-018-26957-6","type":"journal-article","created":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T09:22:42Z","timestamp":1527585762000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Biphasic regulation of tumorigenesis by PTK7 expression level in esophageal squamous cell carcinoma"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9432-1320","authenticated-orcid":false,"given":"Won-Sik","family":"Shin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungsoo","family":"Gim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungho","family":"Won","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7300-9784","authenticated-orcid":false,"given":"Seung-Taek","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,4]]},"reference":[{"key":"26957_CR1","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay, J. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136, E359\u2013386, https:\/\/doi.org\/10.1002\/ijc.29210 (2015).","journal-title":"Int J Cancer"},{"key":"26957_CR2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal, A. et al. Global cancer statistics. CA Cancer J Clin 61, 69\u201390 (2011).","journal-title":"CA Cancer J Clin"},{"key":"26957_CR3","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/S0140-6736(12)60643-6","volume":"381","author":"A Pennathur","year":"2013","unstructured":"Pennathur, A., Gibson, M. K., Jobe, B. A. & Luketich, J. D. Oesophageal carcinoma. Lancet 381, 400\u2013412 (2013).","journal-title":"Lancet"},{"key":"26957_CR4","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1111\/cas.12194","volume":"104","author":"WS Shin","year":"2013","unstructured":"Shin, W. S. et al. Oncogenic role of protein tyrosine kinase 7 in esophageal squamous cell carcinoma. Cancer Sci 104, 1120\u20131126 (2013).","journal-title":"Cancer Sci"},{"key":"26957_CR5","first-page":"2179","volume":"11","author":"K Mossie","year":"1995","unstructured":"Mossie, K. et al. Colon carcinoma kinase-4 defines a new subclass of the receptor tyrosine kinase family. Oncogene 11, 2179\u20132184 (1995).","journal-title":"Oncogene"},{"key":"26957_CR6","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1126\/science.1065817","volume":"294","author":"S Saha","year":"2001","unstructured":"Saha, S. et al. A phosphatase associated with metastasis of colorectal cancer. Science 294, 1343\u20131346 (2001).","journal-title":"Science"},{"key":"26957_CR7","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.3892\/or.2016.4983","volume":"36","author":"X Tian","year":"2016","unstructured":"Tian, X. et al. PTK7 overexpression in colorectal tumors: Clinicopathological correlation and prognosis relevance. Oncol Rep 36, 1829\u20131836 (2016).","journal-title":"Oncol Rep"},{"key":"26957_CR8","first-page":"3403","volume":"8","author":"ST Lee","year":"1993","unstructured":"Lee, S. T., Strunk, K. M. & Spritz, R. A. A survey of protein tyrosine kinase mRNAs expressed in normal human melanocytes. Oncogene 8, 3403\u20133410 (1993).","journal-title":"Oncogene"},{"key":"26957_CR9","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/oxfordjournals.jbchem.a021228","volume":"119","author":"SK Park","year":"1996","unstructured":"Park, S. K., Lee, H. S. & Lee, S. T. Characterization of the human full-length PTK7 cDNA encoding a receptor protein tyrosine kinase-like molecule closely related to chick KLG. J Biochem 119, 235\u2013239 (1996).","journal-title":"J Biochem"},{"key":"26957_CR10","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1042\/BJ20131174","volume":"457","author":"JM Murphy","year":"2014","unstructured":"Murphy, J. M. et al. A robust methodology to subclassify pseudokinases based on their nucleotide-binding properties. Biochem J 457, 323\u2013334 (2014).","journal-title":"Biochem J"},{"key":"26957_CR11","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1042\/BST20160331","volume":"45","author":"AV Jacobsen","year":"2017","unstructured":"Jacobsen, A. V. & Murphy, J. M. The secret life of kinases: insights into non-catalytic signalling functions from pseudokinases. Biochem Soc Trans 45, 665\u2013681 (2017).","journal-title":"Biochem Soc Trans"},{"key":"26957_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fcell.2017.00031","volume":"5","author":"H Berger","year":"2017","unstructured":"Berger, H., Wodarz, A. & Borchers, A. PTK7 Faces the Wnt in Development and Disease. Front Cell Dev Biol 5, 31, https:\/\/doi.org\/10.3389\/fcell.2017.00031 (2017).","journal-title":"Front Cell Dev Biol"},{"key":"26957_CR13","doi-asserted-by":"publisher","first-page":"30562","DOI":"10.1074\/jbc.M115.697615","volume":"290","author":"S Martinez","year":"2015","unstructured":"Martinez, S. et al. The PTK7 and ROR2 Protein Receptors Interact in the Vertebrate WNT\/Planar Cell Polarity (PCP) Pathway. J Biol Chem 290, 30562\u201330572 (2015).","journal-title":"J Biol Chem"},{"key":"26957_CR14","doi-asserted-by":"publisher","first-page":"3729","DOI":"10.1038\/emboj.2011.236","volume":"30","author":"H Peradziryi","year":"2011","unstructured":"Peradziryi, H. et al. PTK7\/Otk interacts with Wnts and inhibits canonical Wnt signalling. EMBO J 30, 3729\u20133740 (2011).","journal-title":"EMBO J"},{"key":"26957_CR15","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1242\/dev.095984","volume":"141","author":"N Bin-Nun","year":"2014","unstructured":"Bin-Nun, N. et al. PTK7 modulates Wnt signaling activity via LRP6. Development 141, 410\u2013421 (2014).","journal-title":"Development"},{"key":"26957_CR16","doi-asserted-by":"publisher","first-page":"4015","DOI":"10.1242\/dev.023556","volume":"135","author":"I Shnitsar","year":"2008","unstructured":"Shnitsar, I. & Borchers, A. PTK7 recruits dsh to regulate neural crest migration. Development 135, 4015\u20134024 (2008).","journal-title":"Development"},{"key":"26957_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/embor.2010.185","volume":"12","author":"F Puppo","year":"2011","unstructured":"Puppo, F. et al. Protein tyrosine kinase 7 has a conserved role in Wnt\/beta-catenin canonical signalling. EMBO Rep 12, 43\u201349 (2011).","journal-title":"EMBO Rep"},{"key":"26957_CR18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nature02677","volume":"430","author":"X Lu","year":"2004","unstructured":"Lu, X. et al. PTK7\/CCK-4 is a novel regulator of planar cell polarity in vertebrates. Nature 430, 93\u201398 (2004).","journal-title":"Nature"},{"key":"26957_CR19","doi-asserted-by":"publisher","first-page":"e14018","DOI":"10.1371\/journal.pone.0014018","volume":"5","author":"L Meng","year":"2010","unstructured":"Meng, L. et al. Silencing of PTK7 in colon cancer cells: caspase-10-dependent apoptosis via mitochondrial pathway. PLoS One 5, e14018, https:\/\/doi.org\/10.1371\/journal.pone.0014018 (2010).","journal-title":"PLoS One"},{"key":"26957_CR20","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1182\/blood-2010-01-262352","volume":"116","author":"T Prebet","year":"2010","unstructured":"Prebet, T. et al. The cell polarity PTK7 receptor acts as a modulator of the chemotherapeutic response in acute myeloid leukemia and impairs clinical outcome. Blood 116, 2315\u20132323 (2010).","journal-title":"Blood"},{"key":"26957_CR21","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1158\/0008-5472.CAN-10-3588","volume":"71","author":"RM Gobble","year":"2011","unstructured":"Gobble, R. M. et al. Expression profiling of liposarcoma yields a multigene predictor of patient outcome and identifies genes that contribute to liposarcomagenesis. Cancer Res 71, 2697\u20132705 (2011).","journal-title":"Cancer Res"},{"key":"26957_CR22","doi-asserted-by":"publisher","first-page":"e90247","DOI":"10.1371\/journal.pone.0090247","volume":"9","author":"J Jin","year":"2014","unstructured":"Jin, J., Ryu, H. S., Lee, K. B. & Jang, J. J. High expression of protein tyrosine kinase 7 significantly associates with invasiveness and poor prognosis in intrahepatic cholangiocarcinoma. PLoS One 9, e90247, https:\/\/doi.org\/10.1371\/journal.pone.0090247 (2014).","journal-title":"PLoS One"},{"key":"26957_CR23","doi-asserted-by":"crossref","first-page":"73242","DOI":"10.18632\/oncotarget.12303","volume":"7","author":"WS Shin","year":"2016","unstructured":"Shin, W. S., Hong, Y., Lee, H. W. & Lee, S. T. Catalytically defective receptor protein tyrosine kinase PTK7 enhances invasive phenotype by inducing MMP-9 through activation of AP-1 and NF-kappaB in esophageal squamous cell carcinoma cells. Oncotarget 7, 73242\u201373256 (2016).","journal-title":"Oncotarget"},{"key":"26957_CR24","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12957-017-1172-x","volume":"15","author":"K Liu","year":"2017","unstructured":"Liu, K. et al. PTK7 is a novel oncogenic target for esophageal squamous cell carcinoma. World J Surg Oncol 15, 105, https:\/\/doi.org\/10.1186\/s12957-017-1172-x (2017).","journal-title":"World J Surg Oncol"},{"key":"26957_CR25","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1016\/j.bbamcr.2015.05.015","volume":"1853","author":"WS Shin","year":"2015","unstructured":"Shin, W. S., Na, H. W. & Lee, S. T. Biphasic effect of PTK7 on KDR activity in endothelial cells and angiogenesis. Biochim Biophys Acta 1853, 2251\u20132260 (2015).","journal-title":"Biochim Biophys Acta"},{"key":"26957_CR26","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1002\/(SICI)1097-0215(19970611)71:6<1061::AID-IJC24>3.0.CO;2-F","volume":"71","author":"DJ Easty","year":"1997","unstructured":"Easty, D. J. et al. Loss of expression of receptor tyrosine kinase family genes PTK7 and SEK in metastatic melanoma. Int J Cancer 71, 1061\u20131065 (1997).","journal-title":"Int J Cancer"},{"key":"26957_CR27","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s00345-011-0767-z","volume":"30","author":"TE Behbahani","year":"2012","unstructured":"Behbahani, T. E. et al. Tyrosine kinase expression profile in clear cell renal cell carcinoma. World J Urol 30, 559\u2013565 (2012).","journal-title":"World J Urol"},{"key":"26957_CR28","first-page":"7881","volume":"7","author":"H Wang","year":"2014","unstructured":"Wang, H. et al. PTK7 protein is decreased in epithelial ovarian carcinomas with poor prognosis. Int J Clin Exp Pathol 7, 7881\u20137889 (2014).","journal-title":"Int J Clin Exp Pathol"},{"key":"26957_CR29","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.3892\/or.2014.3164","volume":"31","author":"JH Kim","year":"2014","unstructured":"Kim, J. H. et al. Protein tyrosine kinase 7 plays a tumor suppressor role by inhibiting ERK and AKT phosphorylation in lung cancer. Oncol Rep 31, 2708\u20132712 (2014).","journal-title":"Oncol Rep"},{"key":"26957_CR30","doi-asserted-by":"publisher","first-page":"e0159182","DOI":"10.1371\/journal.pone.0159182","volume":"11","author":"J Gim","year":"2016","unstructured":"Gim, J., Won, S. & Park, T. LPEseq: Local-Pooled-Error Test for RNA Sequencing Experiments with a Small Number of Replicates. PLoS One 11, e0159182, https:\/\/doi.org\/10.1371\/journal.pone.0159182 (2016).","journal-title":"PLoS One"},{"key":"26957_CR31","doi-asserted-by":"publisher","first-page":"e0123768","DOI":"10.1371\/journal.pone.0123768","volume":"10","author":"AC Lhoumeau","year":"2015","unstructured":"Lhoumeau, A. C. et al. Overexpression of the Promigratory and Prometastatic PTK7 Receptor Is Associated with an Adverse Clinical Outcome in Colorectal Cancer. PLoS One 10, e0123768, https:\/\/doi.org\/10.1371\/journal.pone.0123768 (2015).","journal-title":"PLoS One"},{"key":"26957_CR32","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1158\/1541-7786.MCR-16-0432","volume":"15","author":"SM Messerli","year":"2017","unstructured":"Messerli, S. M., Hoffman, M. M., Gnimpieba, E. Z. & Bhardwaj, R. D. Therapeutic Targeting of PTK7 is Cytotoxic in Atypical Teratoid Rhabdoid Tumors. Mol Cancer Res 15, 973\u2013983 (2017).","journal-title":"Mol Cancer Res"},{"key":"26957_CR33","doi-asserted-by":"publisher","unstructured":"Damelin, M. et al. A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressions. Sci Transl Med 9, pii: eaag2611; https:\/\/doi.org\/10.1126\/scitranslmed.aag2611 (2017).","DOI":"10.1126\/scitranslmed.aag2611"},{"key":"26957_CR34","doi-asserted-by":"publisher","first-page":"E147","DOI":"10.3390\/brainsci7110147","volume":"7","author":"SM Messerli","year":"2017","unstructured":"Messerli, S. M., Hoffman, M. M., Gnimpieba, E. Z., Kohlhof, H. & Bhardwaj, R. D. 4SC-202 as a Potential Treatment for the Pediatric Brain Tumor Medulloblastoma. Brain Sci 7, E147, https:\/\/doi.org\/10.3390\/brainsci7110147 (2017).","journal-title":"Brain Sci"},{"key":"26957_CR35","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/nbt.3838","volume":"35","author":"L Collado-Torres","year":"2017","unstructured":"Collado-Torres, L. et al. Reproducible RNA-seq analysis using recount2. Nat Biotechnol 35, 319\u2013321 (2017).","journal-title":"Nat Biotechnol"},{"key":"26957_CR36","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.bbrc.2008.04.168","volume":"371","author":"WS Shin","year":"2008","unstructured":"Shin, W. S. et al. Soluble PTK7 inhibits tube formation, migration, and invasion of endothelial cells and angiogenesis. Biochem Biophys Res Commun 371, 793\u2013798 (2008).","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-26957-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-26957-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-26957-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T06:11:41Z","timestamp":1671603101000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-26957-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,4]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["26957"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-26957-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,4]]},"assertion":[{"value":"1 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"8519"}}